Policy & Science General Session - Methadone in the Modern Era
-
Register
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29

Policy & Science General Session - Methadone in the Modern Era
Recorded: Thursday, April 4, 2024 to Sunday, April 7, 2024
On-Demand Session
Overview
This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the history of methadone in the US, latest policy updates and how changes will impact practices across the care continuum.
Access to medication for addiction can save lives. However, for decades, stigmatizing regulations have imposed barriers to evidence-based addiction care. Is that about to change? In this session, experts will discuss the history of methadone in the US, latest policy updates and how changes will impact practices across the care continuum. Join the discussion to explore a future focused on patient-centered, individualized care and prepare yourself for the next era in methadone.
The target audience for this Introductory level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This session addresses the following ACGME Competencies: Systems-based Practice
This session addresses the following ICPE Competencies:Roles and Responsibilities, Interprofessional Communication, Teams and Teamwork
Learning Objectives
Upon completion, learners will be able to:
- Describe the effect of structural factors related to methadone on rates of mortality and treatment access in the context of general healthcare for people who use drugs, and to do so from the perspective of community driven and participatory research and practice by and for the same.
- Identify changes that can be made at your OTP that would improve retention in treatment for patients
Registration Rates
| Rate Description | Rate |
| ASAM Member | $29 |
| Non-Member | $39 |
| Associate Member | $19 |
| Resident Member* | $19 |
| Student Member* | $19 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Open: 05/06/2024 - 04/06/2027
User Access Closed: 05/06/2027
Session Instructions
- Click on the Contents tab to watch the on-demand recording.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Stephen Taylor
MD, MPH, DFAPA, DFASAM
Pathway Healthcare
Stephen M. Taylor, MD, MPH, DFAPA, DFASAM is the Chief Medical Officer of Pathway Healthcare, a company that operates 13 outpatient mental health and addiction treatment offices across Alabama, Mississippi, Tennessee, and Texas. Dr. Taylor is board-certified in psychiatry, child and adolescent psychiatry, addiction psychiatry, and addiction medicine. Dr. Taylor is in his 15th season as the Medical Director of the Player Assistance/Anti-Drug Program of the National Basketball Association (NBA) and the National Basketball Players Association (NBPA).
Dr. Taylor is a Distinguished Fellow of the American Psychiatric Association, and a Distinguished Fellow of the American Society of Addiction Medicine (DFASAM). He is Vice Chair of ASAM’s Legislative Advocacy Committee and serves on ASAM’s Public Policy Committee. He is co-chair of ASAM’s Writing Subcommittee on Advancing Racial Justice, which drafted ASAM’s Public Policy Statement on Advancing Racial Justice in Addiction Medicine. He also chairs ASAM’s Delegation to the AMA House of Delegates and is a member of the ASAM Board of Directors.
Dr. Taylor is a certified Medical Review Officer (MRO) and serves on the Board of Directors of the Medical Review Officer Certification Council (MROCC). He also serves on the Drug Testing Advisory Board (DTAB) of the Center for Substance Abuse Prevention of the Substance Abuse and Mental Health Services Administration (SAMHSA), and he serves on the Board of Directors of the Addiction Prevention Coalition, a non-profit community organization in Birmingham, AL.
An honors graduate of Harvard College, with a Master of Public Health degree from the Harvard School of Public Health and a medical degree from Howard University College of Medicine, Dr. Taylor completed “Triple Board” residency in pediatrics, psychiatry, and child and adolescent psychiatry at the Albert Einstein College of Medicine/Bronx Municipal Hospital Center, then completed a fellowship in addiction psychiatry at NYU School of Medicine/Bellevue Hospital Center.
Yngvild Olsen
MD, MPH, DFASAM
Dr. Yngvild Olsen serves as the Acting Director for the Center for Substance Abuse Treatment (CSAT). She has a long history of working within the addiction treatment field to expand access to care and enhance quality. She began her career as the Medical Director for the Johns Hopkins Hospital’s outpatient substance use treatment services while a full-time Assistant Professor in the Department of Medicine at the Johns Hopkins School of Medicine. She subsequently served as the Deputy Health Officer for Maryland’s Harford County Health Department. She led a modernization of publicly funded substance use treatment services in collaboration with State and local partners. She next served as the Vice President of Clinical Affairs for the Baltimore Substance Abuse Systems, then the local addiction authority for Baltimore City. In that position, she played a central role in expanding buprenorphine treatment for opioid addiction in both specialty treatment and general ambulatory medical systems. Dr. Olsen has also served as Medical Consultant to the Maryland Behavioral Health Administration, a clinical expert to the Maryland Addiction Consultation Service at the University of Maryland School of Medicine, and an advisor on addiction interventions to the Baltimore City Health Department. From 2011 to 2021, she served as Medical Director for the Institutes for Behavior Resources/REACH Health Services, a comprehensive outpatient substance use disorder treatment program in Baltimore City. She has held numerous senior volunteer leadership positions in the field of addiction medicine, including vice president of the American Society of Addiction Medicine, president of the Maryland Association for the Treatment of Opioid Dependence, and president of the Maryland/DC Society of Addiction Medicine. She also has served on the boards of the National Council on Alcohol and Drug Dependence-Maryland, Stop Stigma Now, and as a clinical expert to the Providers Clinical Support System (PCSS).
Aaron Ferguson
BSW
Aaron Ferguson, (BSW) is a Regional Impact Manager with Community Medical Services (CMS). CMS is a national provider of medications for people with opioid use disorder. Aaron works to advocate for and implement methadone and buprenorphine treatments in jails, prisons, inpatient settings, and communities in general. Aaron is also on the leadership team of the Urban Survivor’s Union, a national group of advocates for drug user health. Most of what Aaron knows about harm reduction he learned during 15 years of living on the streets of San Francisco and Santa Cruz California as a kid. Traveling to over 30 countries and living in several European countries as a citizen has also taught Aaron that the US has an unnecessarily barbaric way of dealing with people who use drugs. Having received a degree in social work—and upon spending several years examining the scientific literature—Aaron believes that the best way to combat the misinformation and stigma against people who use substances is for those most directly impacted to organize and fight for their own rights. Aaron works tirelessly to help communities accept the overwhelming evidence for harm reduction and MAT, and wants to help bring about a revolution in the US to begin seeing people who use drugs as humans, rather than immoral or diseased subjects.
As a hobby, Aaron produces a long-standing harm reduction podcast called “The Social Exchange with Zach Rhodes”, spotlighting important topics related to harm reduction, and has another podcast called “Narcotica” spotlighting past and current events in the war on drugs. Aaron is a happily married father of 2 who encourages skepticism, reason and science as the paths to enlightenment and discovery. When Aaron is not working, he enjoys running marathons, producing music, scuba diving and most of all spending quality time with his wife and two kids.
Ruth A. Potee
MD, FASAM
Dr. Ruth Potee is a board certified Family Physician and Addiction Medicine physician who works in western Massachusetts. She attended Wellesley College, Yale University School of Medicine and did her residency at Boston University where she remained an assistant professor of Family Medicine for eight years. She is currently the Medical Director for the Franklin County House of Corrections, the Director of Addiction Services for Behavioral Health Network, and the medical director for the Pioneer Valley Regional School District as well as the medical director the Opioid Task Force of Franklin County and the North Quabbin Region. She was named Franklin County Doctor of the Year by the Massachusetts Medical Society in 2015.
Accreditation & Credit Designation Statements
Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
This activity awards 1.25 Nursing contact hours.

PAs
ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 05/06/2027. PAs should only claim credit commensurate with the extent of their participation.
Social Workers
As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.
IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Continuing Education Credits (CEUs)
Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.
Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)
This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
- American Board of Medical Specialties (ABMS)
- American Board of Preventive Medicine (ABPM)
- American Board of Internal Medicine (ABIM)
- American Board of Pediatrics (ABP)
- American Board of Surgery (ABS)
- American Board of Psychiatry and Neurology (ABPN)
- American Board of Addiction Medicine (ABAM)
- Royal College of Physicians and Surgeons of Canada (RCPSC)
- Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons in Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Disclosure Information
In accordance with disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed all financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. Click here to view the full disclosure listing.